TuHURA Biosciences, Inc. (HURA) Stock Ticker
Market factors today
Unlock the full HURA picture
About TuHURA Biosciences, Inc.
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.
HURA stock facts
| Ticker symbol | HURA |
| Exchange | NASDAQ Capital Market |
| Sector | Healthcare |
| Industry | Biotechnology |
| Market cap | $133.7M |
| CEO | James A. Bianco |
| Employees | 22 |
| Headquarters | Tampa, FL, US |
| IPO date | 2013-02-22 |
| Website | www.tuhurabio.com |
What you can see for HURA on Tickr
Live HURA price chart with overlays, the options chain, implied move, IV rank, options flow and Strategy Lab, financial statements and consensus estimates, analyst ratings, catalysts, news with AI scoring, and an AI chat that has read the HURA report.
Rankings
FAQ
What is the ticker symbol for TuHURA Biosciences, Inc.?
The ticker symbol for TuHURA Biosciences, Inc. is HURA, listed on the NASDAQ Capital Market.
What is HURA?
TuHURA Biosciences, Inc. is an immuno-oncology firm that has reached the critical Phase 3 registration stage of clinical development. The company is dedicated to pioneering innovative technologies designed to effectively combat the mechanisms by which cancers develop resistance to existing immunotherapy treatments. Its operations are based in Tampa, Florida.